Cargando…

Towards Curative Cancer Immunotherapy: Overcoming Posttherapy Tumor Escape

The past decade has witnessed the evolvement of cancer immunotherapy as an increasingly effective therapeutic modality, evidenced by the approval of two immune-based products by the FDA, that is, the cancer vaccine Provenge (sipuleucel-T) for prostate cancer and the antagonist antibody against cytot...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Gang, Levitsky, Hyam
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3386616/
https://www.ncbi.nlm.nih.gov/pubmed/22778760
http://dx.doi.org/10.1155/2012/124187